Business
MCAP: Life science group achieves robust growth via acquisitions and innovation in core business areas
MCAP: Life science group achieves robust growth via acquisitions and innovation in core business areas
About this update from Medcap Ab
With a focus on life science, the group drives growth through a buy-and-build strategy, targeting scalable businesses in assistive tech, medtech, and specialty pharma. Strong financial performance is supported by organic growth, acquisitions, and a clear market focus.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.